...looks like this would be one of your competitors.
Not really. It looks to me like this product is a treatment for nociceptive pain, not neuropathic pain like ACV1.
Two different indications, two different markets.
- Forums
- ASX - By Stock
- MBP
- volume building for mbp
volume building for mbp, page-16
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)